Alkame Water Offers the Miami Heat's LeBron James a Solution to His Leg Cramp Problem With a 1-Year Supply of Its Patented Bottled Water Formulation
LAS VEGAS, NV--(Marketwired - Jun 9, 2014) - Alkame Holdings, Inc. (OTCBB: ALKM) (OTCQB: ALKM), a health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products, is pleased to announce its offer to supply the Miami Heat's LeBron James with a 1-year supply of Alkame's patented and proprietary micro-clustered, alkaline, antioxidant and oxygenated bottled water.
Robert Eakle, CEO of Alkame Holdings, Inc., commented, "When LeBron James suffered serious cramping at the end of the NBA Finals Game #1 between the Miami Heat and the San Antonio Spurs last week, I immediately knew that our water could have prevented it because one of most frequent comments we get from elite level athletes that use Alkame water is that it helps combat muscle fatigue and virtually eliminates cramping. Spurs guard and Team Alkame athlete Danny Green was even kind enough to post an Instagram photo for LeBron to let him know that Alkame water was his not so secret weapon against cramping."
http://instagram.com/p/o_bfcMS67v/#
Eakle continued, "Team Alkame loves Danny Green and the Spurs, but we also don't like to see other players suffer out there on the court. That's why we're ready to supply LeBron with all the patented and proprietary Alkame bottled water that he'll need for the next year. In a tight game, when every shot can turn out to be the deciding factor, Miami Heat fans could rest assured that Alkame water would keep their MVP champ ultra-hydrated well past the fourth quarter and into overtime."
Danny Green of the San Antonio Spurs is one of many elite level professional athletes that utilize Alkame bottled water every day to stay ultra-hydrated and to achieve peak performance, on and off the field. Team Alkame athletes include NFL players Darrell Stucky (San Diego Chargers), Robbie Gould (Chicago Bears), and Walter Thurmond (New York Giants), snowboarding legend Cory Cronk, skateboarding pioneers Ray "Bones" Rodriguez and Christian Hosoi, former female world champion skateboarder Julie "Julz Lynn" Kindstrand, and many elite level MMA fighters, such as Amanda Bell, Byron Byrd, Chad Livingston, Clay Harvison, Daniel Swain, Dave Courchaine, Deivison Ribeiro (XFC Featherweight Champion), Jacob Brunelle, Jose Figueroa, Josh Rettinghouse, Julien Williams, Julio Gallegos, Keon Caldwell, Lee Morrison, Phil Daru, Ray Camp, and Socrates Pierre, among other professional athletes.
Not all waters are created equal™. Previous scientific studies and overwhelming anecdotal evidence supports the conclusion that Alkame's patented technology creates water with unique molecular properties that allow it to be absorbed more efficiently and significantly increases the total oxygen available to fuel the body which improves metabolic functions, boosts the immune system, and improves cardio respiratory function. An additional elite level athlete research study is expected to be conducted in the near future.
About Alkame Holdings, Inc.
Alkame Holdings, Inc. is a publicly traded health and technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiary, Alkame Water, Inc., markets and distributes micro-clustered, alkaline, antioxidant and oxygenated bottled water utilizing an exclusive patented formula and technology. Alkame's patented technology creates water with several unique properties which allow the body to absorb and utilize it more efficiently and help to achieve an optimal pH balance. The patented Alkame technology also increases the available oxygen content and absorbability which equates to more fuel for improved metabolic efficiency, boosted immune system, and improved cardio respiratory function.
Not all waters are created equal™. For more information, visit www.alkamewater.com.
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the potential failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
